Home
Scholarly Works
NCIC CTG IND.206: A phase II umbrella trial of...
Conference

NCIC CTG IND.206: A phase II umbrella trial of sunitinib (S) or temsirolimus (T) in advanced rare cancers.

Authors

Dancey J; Krzyzanowska MK; Provencher DM; Cheung WY; Macfarlane RJ; Alcindor T; Ghatage P; Gupta AA; Laurie SA; Sawyer MB

Volume

33

Pagination

pp. 2594-2594

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

May 20, 2015

DOI

10.1200/jco.2015.33.15_suppl.2594

Conference proceedings

Journal of Clinical Oncology

Issue

15_suppl

ISSN

0732-183X
View published work (Non-McMaster Users)

Contact the Experts team